← Back to all substances
N
diazepam
182ms
Level 1
✓ What this shows
- • Reported adverse events from FDA FAERS
- • Descriptive statistics from a locked corpus
- • Data verified with cryptographic hashes
✗ What this is NOT
- • Not medical advice or recommendations
- • Not proof of causality
- • Not a complete safety profile
About this substance
Class: Benzodiazepine [EPC]
INDICATIONS AND USAGE Diazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. In acute alcohol withdrawal, dia...
Known as: Diazepam
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
88,038
Total in FDA
89%
Serious Reports
379
Fatal Outcomes
Seriousness
Serious
447
Non-Serious
53
Sex Distribution
Male
237
Female
253
Unknown
10
Age Distribution
0-17
8
18-40
134
41-64
247
65-84
51
85+
6
Unknown
54
Outcomes
Recovered/Resolved
397
Recovering/Resolving
89
Not Recovered/Not Resolved
241
Recovered with Sequelae
1
Fatal
379
Unknown
630
Top Reported Reactions (click to view reports)
Verification Data
Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-fc9df2
This output reports adverse events from FDA FAERS. It does not constitute medical advice.
Molecular Structure (reference)
Structural visualization for identification only.
This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.
Loading structure...